Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Endometriosis is a painful, chronic condition in which tissue from the uterus inappropriately grows outside the uterus.

Current treatments are limited and include surgery and hormone therapy, which can involve unwanted side effects. New research conducted by the University of Oxford, Baylor College of Medicine, the University of Wisconsin-Madison and Bayer AG, offers new insight into how to treat this debilitating disease.

The researchers performed genetic analyses of humans and rhesus macaques to identify a specific gene, NPSR1, that increases risk of suffering from endometriosis. The results reveal a potential new nonhormonal drug target that may lead to improved therapy. Their results are published in Science Translational Medicine.

Read the full story on the University of Oxford website

Similar stories

Eoghan Mulholland receives prestigious Lee Placito Research Fellowship

Dr Eoghan Mulholland has received the prestigious Lee Placito Research Fellowship in Gastrointestinal Cancer. Eoghan will use this 3-year position to research cell interactions in colorectal cancers.

Ancient gene mutation found to cause rare hereditary condition

UK scientists have found that a 7,000-year-old genetic mutation is responsible for a rare form of hereditary motor neuropathy (HMN).

From bugs to drugs

Decoding the pharmacological goldmine in tick saliva.

Dr Ross Chapman welcomed as EMBO Young Investigator

Wellcome Centre for Human Genetics researcher Dr Ross Chapman has been selected as one of the European Molecular Biology Organisation's Young Investigators for 2018.